The diagnostic value of SERPINB6 was affirmed by ROC and time‐dependent ROC curve analyses, demonstrating moderate accuracy (AUC > 0.7) in glioma prediction (Figure 2D,E). Here, SERPINB6 is linked to central nervous system cancer.